UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000045533
Receipt No. R000051986
Scientific Title An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection
Date of disclosure of the study information 2021/11/01
Last modified on 2022/11/06 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection
Acronym EAGLE
Scientific Title An international, cluster randomised-sequence study of a safe-anastomosis quality improvement intervention to reduce anastomotic leak following right colectomy and ileocaecal resection
Scientific Title:Acronym EAGLE
Region
Japan Asia(except Japan) North America
South America Australia Europe
Africa

Condition
Condition All adult patients (age 18 years and above) undergoing right colectomy with or without primary anastomosis
Classification by specialty
Surgery in general Gastrointestinal surgery Anesthesiology
Operative medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Cohort data suggest that anastomotic leak occurs after 8% of right colectomies causing significant morbidity and mortality. Patient selection, intra-operative factors, and technical variation all contribute to risk of leak. The EAGLE study will assess whether implementation of the European Society of Coloproctology (ESCP) Safe Anastomosis Intervention reduces anastomotic leak following right colectomy
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Anastomotic leak rate following right colectomy at 30-days after surgery
Key secondary outcomes Clinical outcomes within 30-days of surgery including:
a. Reoperation for anastomotic leak
b. Reoperation for any cause
c. Unplanned admission to critical care d. Readmission to hospital
e. Postoperative mortality
f. Length of hospital stay

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Single blind -participants are blinded
Control No treatment
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Other
Interventions/Control_1 ESCP Safe Anastomosis quality improvement intervention
Interventions/Control_2 Pre-intervention data will act as control data
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit
18 years-old >=
Gender Male and Female
Key inclusion criteria Inclusion criteria

Adults >=18 years of age.

Right colectomy, defined as any colonic transection with the distal resection margin proximal to the splenic flexure.

Procedures for any pathology (benign or malignant), via any operative approach (open, laparoscopic, robotic or converted).

Patients undergoing elective (during a planned admission), expedited or emergency surgery (during an unplanned admission).

Patients undergoing colectomy and a synchronous procedure on a different organ e.g. hepatic metastatectomy.
Key exclusion criteria Exclusion criteria
Patients undergoing more than one gastrointestinal anastomosis during the index operation.

In Crohn's disease, additional upstream strictureplasty or resection/anastomosis to treat disease or strictures at the same operation.

Patients undergoing concurrent hyperthermic intraperitoneal chemotherapy (HIPEC) and/or cytoreductive surgery.

Individual patients should only be included in EAGLE once. Following the index EAGLE study procedure, patients undergoing further operative treatment within the study window should not have repeated entries created.
Target sample size 4400

Research contact person
Name of lead principal investigator
1st name Akihiko
Middle name
Last name Horiguchi
Organization Fujita Health University Bantane Hospital
Division name Department of Gastroenterological Surgery
Zip code 454-8509
Address 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan
TEL 052-321-8171
Email akihori@fujita-hu.ac.jp

Public contact
Name of contact person
1st name Akihiko
Middle name
Last name Horiguchi
Organization Fujita Health University Bantane Hospital
Division name Department of Gastroenterological Surgery
Zip code 454-8509
Address 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan
TEL 052-321-8171
Homepage URL
Email akihori@fujita-hu.ac.jp

Sponsor
Institute Fujita Health University
Institute
Department

Funding Source
Organization Fujita Health University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor University of Birmingham
Name of secondary funder(s) the European Society of Coloproctology (ESCP)

IRB Contact (For public release)
Organization Fujita Health University Bantane Hospital
Address 3-6-10 Otoubashi, Nakagawa-ku, Nagoya City, Aichi, 454-8509, Japan
Tel 052-321-8171
Email akihori@fujita-hu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 11 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 09 Month 21 Day
Date of IRB
2021 Year 10 Month 25 Day
Anticipated trial start date
2021 Year 11 Month 01 Day
Last follow-up date
2022 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 09 Month 21 Day
Last modified on
2022 Year 11 Month 06 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051986